Cyclic derivatives as modulators of chemokine receptor activity
US7045521B2 · kind B2 · utility
1Cited by
14References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 12, 2003 |
| Grant date | May 16, 2006 |
| Priority date | — |
| Expiry date | Feb 3, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application describes modulators of MCP-1 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.